• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定端粒酶逆转录酶启动子突变型甲状腺癌细胞系中的等位基因特异性调控。

Characterization of Allele-Specific Regulation of Telomerase Reverse Transcriptase in Promoter Mutant Thyroid Cancer Cell Lines.

机构信息

Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Department of Molecular Biology and Genetics, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

出版信息

Thyroid. 2020 Oct;30(10):1470-1481. doi: 10.1089/thy.2020.0055. Epub 2020 May 4.

DOI:10.1089/thy.2020.0055
PMID:32228178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7583328/
Abstract

Telomerase reverse transcriptase () promoter mutations play a role in carcinogenesis and are found in both tumors and cancer cell lines. promoter methylation, transcription factor binding, chromatin remodeling, and alternative splicing are also known to play an integral role in regulation. Using nanopore Cas9 targeted sequencing, we characterized allele-specific methylation in thyroid cancer cell lines heterozygous for the promoter mutation. Furthermore, using chromatin immunoprecipitation followed by Sanger sequencing, we probed allele-specific binding of the transcription factors (GA binding protein transcription factor subunit alpha) and , as well as the chromatin marks H3K4me3 and H3K27me3. Finally, using coding single nucleotide polymorphisms and the long-read sequencing, we examined complementary DNA for monoallelic expression (MAE). We found the mutant promoter allele to be significantly less methylated than wild type, while more methylated in the gene body in heterozygous mutant cell lines. We demonstrated that the transcriptional activators and bind only to the mutant allele. In addition, the activating and repressive chromatin marks H3K4me3 and H3K27me3, respectively, bind mutant and wild-type alleles exclusively. Finally, in heterozygous mutant cell lines, exhibits from the mutant allele only. In summary, by employing new long-read sequencing methods, we were able to definitively demonstrate allele-specific DNA methylation, histone modifications, transcription factor binding, and the resulting monoallelic transcription in cell lines with heterozygous mutations.

摘要

端粒酶逆转录酶 () 启动子突变在肿瘤发生中起作用,并且在肿瘤和癌细胞系中都有发现。启动子甲基化、转录因子结合、染色质重塑和选择性剪接也被认为在调控中发挥着重要作用。我们使用纳米孔 Cas9 靶向测序,对杂合 启动子突变的甲状腺癌细胞系中的等位基因特异性甲基化进行了特征描述。此外,我们通过染色质免疫沉淀 followed by Sanger sequencing,探测了转录因子和的等位基因特异性结合,以及染色质标记 H3K4me3 和 H3K27me3。最后,我们使用编码单核苷酸多态性和长读测序,检查了单等位基因表达(MAE)的 cDNA。我们发现,与野生型相比,突变的启动子等位基因的甲基化程度显著降低,而在杂合 突变细胞系中的基因体中则被更多地甲基化。我们证明转录激活因子和仅与突变的 等位基因结合。此外,激活和抑制染色质标记 H3K4me3 和 H3K27me3 分别与突变和野生型等位基因特异性结合。最后,在杂合突变细胞系中,仅从突变等位基因表达。总之,通过采用新的长读测序方法,我们能够明确地证明杂合 突变细胞系中存在等位基因特异性 DNA 甲基化、组蛋白修饰、转录因子结合以及由此产生的单等位基因转录。

相似文献

1
Characterization of Allele-Specific Regulation of Telomerase Reverse Transcriptase in Promoter Mutant Thyroid Cancer Cell Lines.鉴定端粒酶逆转录酶启动子突变型甲状腺癌细胞系中的等位基因特异性调控。
Thyroid. 2020 Oct;30(10):1470-1481. doi: 10.1089/thy.2020.0055. Epub 2020 May 4.
2
Characterization of human telomerase reverse transcriptase promoter methylation and transcription factor binding in differentiated thyroid cancer cell lines.人端粒酶逆转录酶启动子甲基化及转录因子结合在分化型甲状腺癌细胞系中的特征。
Genes Chromosomes Cancer. 2019 Aug;58(8):530-540. doi: 10.1002/gcc.22735. Epub 2019 Feb 10.
3
Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers.端粒酶逆转录酶(TERT)启动子突变、向活性染色质转变以及多种癌症中的单等位基因TERT表达
Genes Dev. 2015 Nov 1;29(21):2219-24. doi: 10.1101/gad.269498.115. Epub 2015 Oct 29.
4
Allele-Specific DNA Methylation and Its Interplay with Repressive Histone Marks at Promoter-Mutant TERT Genes.等位基因特异性 DNA 甲基化及其与启动子突变 TERT 基因抑制性组蛋白标记的相互作用。
Cell Rep. 2017 Dec 26;21(13):3700-3707. doi: 10.1016/j.celrep.2017.12.001.
5
Allele-specific proximal promoter hypomethylation of the telomerase reverse transcriptase gene (TERT) associates with TERT expression in multiple cancers.端粒酶逆转录酶基因(TERT)的等位基因特异性近端启动子低甲基化与多种癌症中的 TERT 表达相关。
Mol Oncol. 2020 Oct;14(10):2358-2374. doi: 10.1002/1878-0261.12786. Epub 2020 Sep 11.
6
Interplay between TERT promoter mutations and methylation culminates in chromatin accessibility and TERT expression.端粒酶逆转录酶启动子突变与甲基化相互作用最终导致染色质可及性和端粒酶逆转录酶表达。
PLoS One. 2020 Apr 8;15(4):e0231418. doi: 10.1371/journal.pone.0231418. eCollection 2020.
7
TERT Promoter Mutations Enhance Telomerase Activation by Long-Range Chromatin Interactions.端粒酶逆转录酶(TERT)启动子突变通过长程染色质相互作用增强端粒酶激活
Cancer Discov. 2016 Nov;6(11):1212-1214. doi: 10.1158/2159-8290.CD-16-1050.
8
CTCF mediates the TERT enhancer-promoter interactions in lung cancer cells: identification of a novel enhancer region involved in the regulation of TERT gene.CTCF 介导肺癌细胞中的 TERT 增强子-启动子相互作用:鉴定参与 TERT 基因调控的新型增强子区域。
Int J Cancer. 2014 May 15;134(10):2305-13. doi: 10.1002/ijc.28570. Epub 2013 Nov 14.
9
TERT promoter mutations and GABP transcription factors in carcinogenesis: More foes than friends.端粒酶反转录酶启动子突变与 GABP 转录因子在肿瘤发生中的作用:是敌是友尚未可知。
Cancer Lett. 2020 Nov 28;493:1-9. doi: 10.1016/j.canlet.2020.07.003. Epub 2020 Aug 6.
10
GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression.GABPA 通过调控 DICER1 的表达抑制甲状腺乳头状癌的侵袭转移。
Oncogene. 2019 Feb;38(7):965-979. doi: 10.1038/s41388-018-0483-x. Epub 2018 Sep 4.

引用本文的文献

1
AURKB and PI3K/AKT/mTOR pathways converge to regulate expression.AURKB和PI3K/AKT/mTOR信号通路相互作用以调控表达。
iScience. 2025 Jul 24;28(8):113194. doi: 10.1016/j.isci.2025.113194. eCollection 2025 Aug 15.
2
The immortality mechanism of TERT promoter mutant cancers is self-reinforcing and reversible.端粒酶逆转录酶(TERT)启动子突变型癌症的永生机制具有自我强化性且是可逆的。
Mol Cell. 2025 Jun 19;85(12):2337-2354.e9. doi: 10.1016/j.molcel.2025.05.026. Epub 2025 Jun 12.
3
Mutational Landmarks in Anaplastic Thyroid Cancer: A Perspective of a New Treatment Strategy.间变性甲状腺癌的突变标志物:一种新治疗策略的视角
J Clin Med. 2025 Apr 23;14(9):2898. doi: 10.3390/jcm14092898.
4
The promising role of nanopore sequencing in cancer diagnostics and treatment.纳米孔测序在癌症诊断和治疗中的潜在作用。
Cell Insight. 2025 Jan 18;4(2):100229. doi: 10.1016/j.cellin.2025.100229. eCollection 2025 Apr.
5
Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics.端粒、端粒酶与癌症:作用机制、生物标志物及治疗方法
Exp Hematol Oncol. 2025 Jan 27;14(1):8. doi: 10.1186/s40164-025-00597-9.
6
Novel method for detecting frequent TERT promoter hot spot mutations in bladder cancer samples.新型方法检测膀胱癌样本中 TERT 启动子热点突变。
Clin Exp Med. 2024 Aug 14;24(1):192. doi: 10.1007/s10238-024-01464-3.
7
TERT upstream promoter methylation regulates TERT expression and acts as a therapeutic target in TERT promoter mutation-negative thyroid cancer.端粒酶逆转录酶(TERT)上游启动子甲基化调控TERT表达,并作为TERT启动子突变阴性甲状腺癌的治疗靶点。
Cancer Cell Int. 2024 Aug 3;24(1):271. doi: 10.1186/s12935-024-03459-2.
8
Application of third-generation sequencing in cancer research.第三代测序技术在癌症研究中的应用。
Med Rev (2021). 2021 Oct 21;1(2):150-171. doi: 10.1515/mr-2021-0013. eCollection 2021 Dec.
9
Combining old and new concepts in targeting telomerase for cancer therapy: transient, immediate, complete and combinatory attack (TICCA).在癌症治疗中靶向端粒酶方面结合新旧概念:短暂、即时、完全和联合攻击(TICCA)。
Cancer Cell Int. 2023 Sep 7;23(1):197. doi: 10.1186/s12935-023-03041-2.
10
Regulation and clinical potential of telomerase reverse transcriptase (TERT/hTERT) in breast cancer.端粒酶逆转录酶(TERT/hTERT)在乳腺癌中的调控作用及其临床潜力。
Cell Commun Signal. 2023 Aug 23;21(1):218. doi: 10.1186/s12964-023-01244-8.

本文引用的文献

1
Targeted nanopore sequencing with Cas9-guided adapter ligation.靶向纳米孔测序与 Cas9 引导的接头连接。
Nat Biotechnol. 2020 Apr;38(4):433-438. doi: 10.1038/s41587-020-0407-5. Epub 2020 Feb 10.
2
ETS Factor ETV5 Activates the Mutant Telomerase Reverse Transcriptase Promoter in Thyroid Cancer.ETS 因子 ETV5 在甲状腺癌中激活突变端粒酶逆转录酶启动子。
Thyroid. 2019 Nov;29(11):1623-1633. doi: 10.1089/thy.2018.0314. Epub 2019 Oct 29.
3
Aberrant DNA methylation defines isoform usage in cancer, with functional implications.异常的 DNA 甲基化定义了癌症中异构体的使用,具有功能意义。
PLoS Comput Biol. 2019 Jul 22;15(7):e1007095. doi: 10.1371/journal.pcbi.1007095. eCollection 2019 Jul.
4
Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies.全面的人类甲状腺癌细胞系遗传学特征分析:用于临床前研究的验证性面板。
Clin Cancer Res. 2019 May 15;25(10):3141-3151. doi: 10.1158/1078-0432.CCR-18-2953. Epub 2019 Feb 8.
5
Characterization of human telomerase reverse transcriptase promoter methylation and transcription factor binding in differentiated thyroid cancer cell lines.人端粒酶逆转录酶启动子甲基化及转录因子结合在分化型甲状腺癌细胞系中的特征。
Genes Chromosomes Cancer. 2019 Aug;58(8):530-540. doi: 10.1002/gcc.22735. Epub 2019 Feb 10.
6
Minimap2: pairwise alignment for nucleotide sequences.Minimap2:核苷酸序列的两两比对。
Bioinformatics. 2018 Sep 15;34(18):3094-3100. doi: 10.1093/bioinformatics/bty191.
7
Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer.BRAF V600E/丝裂原活化蛋白激酶途径通过FOS/GABP对人类癌症中突变型端粒酶逆转录酶的调控
Nat Commun. 2018 Feb 8;9(1):579. doi: 10.1038/s41467-018-03033-1.
8
Allele-Specific DNA Methylation and Its Interplay with Repressive Histone Marks at Promoter-Mutant TERT Genes.等位基因特异性 DNA 甲基化及其与启动子突变 TERT 基因抑制性组蛋白标记的相互作用。
Cell Rep. 2017 Dec 26;21(13):3700-3707. doi: 10.1016/j.celrep.2017.12.001.
9
Assessing Telomerase Activities in Mammalian Cells Using the Quantitative PCR-Based Telomeric Repeat Amplification Protocol (qTRAP).使用基于定量PCR的端粒重复序列扩增协议(qTRAP)评估哺乳动物细胞中的端粒酶活性。
Methods Mol Biol. 2017;1587:95-101. doi: 10.1007/978-1-4939-6892-3_9.
10
Detecting DNA cytosine methylation using nanopore sequencing.利用纳米孔测序检测 DNA 胞嘧啶甲基化。
Nat Methods. 2017 Apr;14(4):407-410. doi: 10.1038/nmeth.4184. Epub 2017 Feb 20.